![Everardus Orlemans](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Everardus Orlemans
Plus aucun poste en cours
Provenance du réseau au premier degré de Everardus Orlemans
Entité | Type d'entité | Industrie | |
---|---|---|---|
15
| Subsidiary | Pharmaceuticals: Major | 15 |
Organon Pharmaceuticals USA, Inc.
![]() Organon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Organon Pharmaceutical USA, Inc. markets and distributes pharmaceutical products. Its products include contraceptives and anesthetics, as well as treatments for mental health disorders. The company is headquartered in Roseland, NJ.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Everardus Orlemans via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
JOHNSON & JOHNSON | Pharmaceuticals: Major | Director/Board Member President Sales & Marketing | |
University of Tennessee | College/University | Doctorate Degree | |
NC Life Sciences Organization
![]() NC Life Sciences Organization Miscellaneous Commercial ServicesCommercial Services North Carolina Biosciences Organization is non-profit organization, which focuses on legislative monitoring and lobbying activities at the state and federal level. The company was founded in 1994 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Chairman | |
Ortho-McNeil Pharmaceutical LLC
![]() Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing | |
Envisia Therapeutics, Inc.
![]() Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC. | Biotechnology | Founder | |
Ortho-mcneil Neurologics, Inc. | President | ||
OLD API WIND-DOWN LTD. | Pharmaceuticals: Major | Director/Board Member | |
LIQUIDIA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer | |
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Pharmaceuticals: Major | Chief Executive Officer | |
Pathalys Pharma, Inc.
![]() Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | Pharmaceuticals: Major | Chief Executive Officer | |
Catalys Pacific LLC
![]() Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | Investment Managers | Private Equity Investor | |
EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Director/Board Member | |
The North Carolina Biotechnology Center
![]() The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Internet Software/Services | Director/Board Member | |
Unc Eshelman School of Pharmacy Foundation | Chairman | ||
University of North Carolina at Chapel Hill | College/University | Masters Business Admin | |
Centocor, Inc.
![]() Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | President | |
Cardinal Capital Management LLC
![]() Cardinal Capital Management LLC Investment ManagersFinance Founded in 1995, Cardinal Capital Management LLC is a registered investment advisor located in Greenwich, Connecticut. The firm provides advisory services on a discretionary basis to their clients, which include public and private institutions, corporations, public and private pension plans, investment companies, foundations and endowments, mutual funds and high net-worth individuals. Clients invest through separately managed accounts, in one of the mutual funds Cardinal sub-advises, or in one or both of the limited partnerships Cardinal manages. | Investment Managers | Corporate Officer/Principal | |
JDRF International
![]() JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Simmons University | College/University | Graduate Degree | |
Rensselaer Polytechnic Institute | College/University | Undergraduate Degree | |
Harvard Kennedy School of Government | College/University | Undergraduate Degree | |
TELOMIR PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
MIRA PHARMACEUTICALS, INC. | Pharmaceuticals: Other | Chairman | |
MYMD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
MyMD Pharmaceuticals (Florida), Inc.
![]() MyMD Pharmaceuticals (Florida), Inc. Pharmaceuticals: MajorHealth Technology MyMD Pharmaceuticals (Florida), Inc. is a pharmaceutical company. The company is headquartered in Tampa, FL. | Pharmaceuticals: Major | President | |
Georgetown University School of Medicine | College/University | Doctorate Degree | |
Chapman Pharmaceutical Consulting, Inc.
![]() Chapman Pharmaceutical Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Chapman Pharmaceutical Consulting, Inc. engages in biotechnology consultation services. It provides expert medical consultation on the development and management of domestic and global product development programs for biotech, pharmaceutical, and medical device products. The company was founded by Christopher C. Chapman Jr. and is headquartered in Upper Marlboro, MD. | Miscellaneous Commercial Services | Chief Executive Officer | |
IQVIA RDS Consulting, Inc.
![]() IQVIA RDS Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services IQVIA RDS Consulting, Inc. provides global regulatory, compliance, and validation consulting services. The company offers strategic regulatory consulting in the areas of quality systems development and optimization, FDA enforcement solutions, validation, and bioresearch monitoring. It provides services to the pharmaceutical, biotechnology, and medical device industries. The company was founded in 2001 and is located in Vernon Hills, IL. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Chapman Pharmaceutical Health Foundation | Founder | ||
REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
EMD Pharmaceuticals, Inc.
![]() EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Pharmaceuticals: Major | General Counsel | |
Harvard Law School | College/University | Graduate Degree | |
Wellesley College | College/University | Undergraduate Degree | |
CLARUS THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Third Rock Ventures LLC
![]() Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
InteRNA Technologies BV
![]() InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Director/Board Member | |
MENDUS AB | Biotechnology | Director/Board Member | |
DCPrime BV
![]() DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Aduro Biotech Europe BV | Chief Tech/Sci/R&D Officer | ||
Ireya Consulting BV | Corporate Officer/Principal | ||
AM-Pharma BV
![]() AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Chief Tech/Sci/R&D Officer | |
University of Amsterdam | College/University | Graduate Degree | |
University of Leiden | College/University | Doctorate Degree | |
Organon NV
![]() Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Schering-Plough Research Institute
![]() Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Medical Specialties | Corporate Officer/Principal |
Statistiques
Internationale
Etats-Unis | 39 |
Pays-Bas | 9 |
Canada | 2 |
Japon | 2 |
Suède | 2 |
Sectorielle
Health Technology | 28 |
Consumer Services | 11 |
Commercial Services | 5 |
Finance | 4 |
Technology Services | 2 |
Opérationnelle
Director/Board Member | 60 |
Corporate Officer/Principal | 28 |
President | 22 |
Independent Dir/Board Member | 14 |
Undergraduate Degree | 13 |
Relations les plus connectées
Insiders | |
---|---|
Neal Fowler | 17 |
Andrea van Elsas | 16 |
Christopher Chapman | 14 |
Elizabeth Cermak | 13 |
Bruce A. Tomason | 12 |
Ted G. Wood | 11 |
Jacques F. Réjeange | 10 |
Paul J. Rizzo | 10 |
James R. Butler | 9 |
Angela Larson | 9 |
James Joseph Mauzey | 8 |
John G. Fort | 7 |
Gilda Marie Thomas | 6 |
Marshall E. Reese | 6 |
Kristina M. Adomonis | 5 |
- Bourse
- Insiders
- Everardus Orlemans
- Connexions Sociétés